Cure for the common cold FINALLY?
Cure for the Common Cold:
The Biota pharmaceutical company is close to a cure for the common cold. Their new antiviral compound, Vapendavir, shortens the length of colds by 33%. Researcher Dr. Robert Stirling says, “If this reduces the intensity and duration of a respiratory cold, especially in asthmatics, it is an important finding. I think eventually we will be able to incorporate this treatment into our usual practice and we will find the economic benefits will outweigh health costs of treating infected patients. This could signal the death of the sickie.”